Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome

Frontiers of Hormone Research

Volumn 40, Issue , 2013, Pages 40-50

  Carmina, Enrico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; CHEMERIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN OMENTIN; RESISTIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASPIN; LOW DENSITY LIPOPROTEIN; OMENTIN;

ARTICLE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DISEASE COURSE; HORMONE RELEASE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN SECRETION; ABDOMINAL FAT; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SECRETION (PROCESS); ADRENERGIC SYSTEM; ATHEROGENESIS; DISEASE SEVERITY; INFLAMMATION;

ABDOMINAL FAT; ADIPOKINES; ADIPONECTIN; ANDROGENS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 84870266098     PISSN: 03013073     EISSN: 16623762     Source Type: Book Series    
DOI: 10.1159/000341840     Document Type: Article

References (34)

1. Carmina E: Metabolic syndrome in polycystic ovary syndrome. Min Ginecol 2006;58:109-114.
2. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G, Rini GB: Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007;92:2500-2505.
3. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-1935.
4. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA: Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006;154:141-145.
5. Rizzo M, Longo RA, Guastella E, Rini GB, Carmina E: Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome. J Endocrinol Invest 2011;34:422-426.
6. Halberg N, Wernstedt-Asterholm I, Scherer PE: The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008;37:753-768.
7. Gautron L, Elmquist JK: Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 2011;121:2087-2093.
8. Enriori PJ, Sinnayah P, Simonds SE, Garcia Rudaz C, Cowley MA: Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci 2011;31:12189-12197.
9. Guerre-Millo M: Adiponectin: an update. Diabetes Metab 2008;34:12-18.
10. Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R: Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syn drome. Fertil Steril 2008;89:642-648.
11. Matsuzawa Y: Adiponectin: a key player in obesity related disorders. Curr Pharm Des 2010;16:1896-1901.
12. Cook JR, Semple RK: Hypoadiponectinemia -cause or consequence of human 'insulin resistance'? J Clin Endocrinol Metab 2010;95:1544-1554.
13. Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, Kark JD: Adiponectin and lipoprotein particle size. Diabetes Care 2009;32:1317-1319.
14. Schwartz DR, Lazar MA: Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 2011;22:259-265.
15. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A: Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006;49:744-747.
16. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, Jang HC, Kim MS: Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 2011;75:628-635.
17. Kim SM, Cho GJ, Yannakoulia M, Hwang TG, Kim IH, Park EK, Mantzoros CS: Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011;60:1294-1299.
18. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y: Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011;408:339-343.
19. Shang FJ, Wang JP, Liu XT, Zheng QS, Xue YS, Wang B, Zhao LY: Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011;16:657-662.
20. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH: Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011;22:103.
21. Ernst MC, Sinal CJ: Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010;21:660-667.
22. Feng X, Li P, Zhou C, Jia X, Kang J: Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome. Biomarkers 2012;17:248-253.
23. Conroy R, Espinal Y, Fennoy I, Accacha S, Boucher-Berry C, Carey DE, Close S, DeSantis D, Gupta R, Hassoun AA, Iazzetti L, Jacques FJ, Jean AM, Michel L, Pavlovich K, Rapaports R, Rosenfeld W, Shamoon E, Shelov S, Speiser PW, Ten S, Rosenbaum M: Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab 2011;24:913-919.
24. Lumeng CN, Saltiel AR: Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111-2117.
25. Samaan MC: The macrophage at the intersection of immunity and metabolism in obesity. Diabetol Metab Syndr 2011;3:29.
26. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA: Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005;152:389-394.
27. Sathyapalan T, Atkin SL: Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm 2010;2010:758656.
28. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA: Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 2009;91:1332-1335.
29. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS: Omentin-1, a novel adipokine, is decreased in overweight insulinresistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008;57:801-808.
30. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS: Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 2006;91:5022-5028.
31. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS: Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008;57:1501-1507.
32. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, Heutling D, Lewandowski KC, O'Hare JP, Lehnert H, Randeva HS: Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009;58:1971-1977.
33. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, Lam KS: Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005;280: 18073-18080.
34. González F: Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 2012;77:300-305.